Category: The Sen-Jam Perspective

Inflammation

The Biggest Problem in Modern Medicine? Inflammation

The Biggest Problem in Modern Medicine? Inflammation. Wall Street missed this. We didn’t. Most investors are still betting on yesterday’s drug models.
Read More
Sachs Biopharma Event June

Sen-Jam Pharmaceutical Takes the Stage European Biopharma Obesity Innovation For...

Sen-Jam Speaks at the Sachs European Biopharma Obesity Innovation Forum in Leipzig, Germany—a gathering of some of the brightest minds working to combat one of the world’s most urgent health crises.
Read More
Group 15235 1 1 (1)

The End of Sickcare: From the Inside Out: A Spotlight on Cellular Longevity at t...

There are rare moments when political urgency, scientific progress, and cultural appetite collide — creating the conditions for real transformation. This may be one of them. With skyrocketing healthcare costs…
Read More
Group 1000001207 (1)

Behind the Breakthrough: Strategic Insights from Sen-Jam’s Executive Leade...

In March 2025, Sen-Jam Pharmaceutical hosted a pivotal webinar in collaboration with Destum Partners, a premier strategic advisory firm known for driving success in biotech partnerships, licensing, and M&A…
Read More
Mask Group (17)

Sen-Jam Pharmaceutical Announces Planned AI Initiative for Molecule Repurposing

HUNTINGTON, N.Y., Jan. 10, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical (“Sen-Jam”), a pioneer in innovative inflammatory care, today announced a planned new initiative for use of leading-edge AI tools…
Read More

Where the Next Spark Becomes Tomorrow’s Headline

 

Our newsroom of scientists, strategists, and culture-watchers tracks the earliest pulses in biology, policy, and public conversation—translating fresh data into actionable perspective before the rest of pharma blinks. Stay tuned, stay sharp, and stay upstream with us.

Subscribe for Fresh Signals
MEDIA INQUIRIES

Media Inquiry